Mediclinic International Ltd Merger with Al Noor Informative Notice Mediclinic International Ltd (South Africa): Merger with Al Noor Hospitals Group (UK) - Informative Notice FTSE/JSE Africa Index Series 15 January 2016 Following shareholder approval and subject to the completion of the scheme of arrangement between Mediclinic International Ltd (South Africa, ZAE000074142, B0PGJF0) and Al Noor Hospitals Group (UK, GB00B8HX8Z88, B8HX8Z8), whereby Mediclinic International Ltd shareholders will receive 0.625 Al Noor Hospitals Group shares for every Mediclinic International Ltd share held, FTSE/JSE is anticipating the following index treatment in the FTSE/JSE Index Series: Wednesday 27 January 2016 (after market close) FTSE/JSE will issue a notice confirming all FTSE/JSE Index changes effective on both 1 February and 9 February. Friday 29 January 2016 Last day of dealing in Mediclinic International Ltd shares. Monday 01 February 2016 (from start of trading) Mediclinic International Ltd (B0PGJF0) will be replaced by Al Noor Hospitals Group (Sedol TBA) in the FTSE/JSE Indices. In order to avoid index tracking errors, the Al Noor Hospitals Group shares will be added at the equivalent offer terms’ value to Mediclinic International’s last traded price. There will be no index divisor change. Monday 08 February 2016 Al Noor Hospitals Group will change its name to Mediclinic International plc. Tuesday 09 February 2016 (from start of trading) Mediclinic International plc will remain in the FTSE/JSE Indices. All index changes to bring Mediclinic’s index shares in line with the JSE issued shares (as notified after market close on Wednesday 27 January 2016) will become effective. Please note: All details are based on the current timetable. For further information or general enquiries please contact us at info@ftse.com or indices@jse.co.za or call: Client Services in UK: Tel: +44 (0) 20 7866 1810 Client Services in EMEA: Tel: +44 (0) 20 7866 1810 Client Services in US: New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139 Client Services in Asia Pacific: Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61 (2) 9293 2864 Japan + 81 (3) 3581 2764 JSE Limited: Tel: +27 11 520 7137 Alternatively please visit our website at www.ftse.com or www.ftsejse.co.za Terms of Use | Copyright © FTSE Date: 15/01/2016 05:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.